Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

ClinicalTrials.gov ID: NCT04053387

Public ClinicalTrials.gov record NCT04053387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term, Open-Label, Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% for the Treatment of Plaque Psoriasis in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a long-term, open-label, multicenter, study to evaluate the safety and efficacy of topical tapinarof cream, 1% in adults with plaque psoriasis. Subjects in this study completed treatment in 1 of 2 Phase 3 pivotal efficacy and safety studies (Study DMVT-505-3001 or Study DMVT-505-3002). This study will consist of up to 40 weeks of treatment and a 4-week safety follow-up period.

Study identification

NCT ID
NCT04053387
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
763 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 12, 2019
Primary completion
Apr 5, 2021
Completion
Apr 5, 2021
Last update posted
Aug 5, 2025

2019 – 2021

United States locations

U.S. sites
85
U.S. states
34
U.S. cities
77
Facility City State ZIP Site status
Dermavant Investigative Site Birmingham Alabama 35205
Dermavant Investigative Site Phoenix Arizona 85032
Dermavant Investigative Site Bryant Arkansas 72022
Dermavant Investigative Site Fort Smith Arkansas 72916
Dermavant Investigative Site Fountain Valley California 92708
Dermavant Investigative Site Fremont California 94538
Dermavant Investigative Site Fresno California 93720
Dermavant Investigative Site Los Angeles California 90033
Dermavant Investigative Site Los Angeles California 90045
Dermavant Investigative Site Northridge California 91324
Dermavant Investigative Site Oceanside California 92056
Dermavant Investigative Site San Diego California 92123
Dermavant Investigative Site Santa Ana California 92701
Dermavant Investigative Site Santa Monica California 90404
Dermavant Investigative Site Denver Colorado 80210
Dermavant Investigative Site Cromwell Connecticut 06416
Dermavant Investigative Site Boca Raton Florida 33431
Dermavant Investigative Site Boynton Beach Florida 33437
Dermavant Investigative Site Hialeah Florida 33016
Dermavant Investigative Site Margate Florida 33063
Dermavant Investigative Site Miami Florida 33144
Dermavant Investigative Site Miramar Florida 33027
Dermavant Investigative Site Boise Idaho 83713
Dermavant Investigative Site Rolling Meadows Illinois 60008
Dermavant Investigative Site Evansville Indiana 47714
Dermavant Investigative Site Indianapolis Indiana 46250
Dermavant Investigative Site New Albany Indiana 47150
Dermavant Investigative Site Plainfield Indiana 46168
Dermavant Investigative Site Overland Park Kansas 66215
Dermavant Investigative Site Louisville Kentucky 40217
Dermavant Investigative Site Owensboro Kentucky 42303
Dermavant Investigative Site Baton Rouge Louisiana 70809
Dermavant Investigative Site New Orleans Louisiana 70115
Dermavant Investigative Site Rockville Maryland 20850
Dermavant Investigative Site Boston Massachusetts 02115
Dermavant Investigative Site Bay City Michigan 48706
Dermavant Investigative Site Clarkston Michigan 48346
Dermavant Clinical Site Detroit Michigan 48202
Dermavant Investigational Site Detroit Michigan 48202
Dermavant Investigative Site Fort Gratiot Michigan 48059
Dermavant Investigative Site Warren Michigan 48088
Dermavant Investigative Site Fridley Minnesota 55432
Dermavant Investigative Site Saint Joseph Missouri 64506
Dermavant Investigative Site Omaha Nebraska 68144
Dermavant Clinical Site Las Vegas Nevada 89148
Dermavant Investigative Site Las Vegas Nevada 89148
Dermavant Investigative Site East Windsor New Jersey 08520
Dermavant Investigative Site Hackensack New Jersey 07601
Dermavant Investigative Site Verona New Jersey 07044
Dermavant Clinical Site Brooklyn New York 11203
Dermavant Investigative Site Kew Gardens New York 11374
Dermavant Investigative Site New York New York 10029
Dermavant Investigative Site Rochester New York 14623
Dermavant Investigative Site Stony Brook New York 11790
Dermavant Clinical Site Watertown New York 13601
Dermavant Investigative Site Cary North Carolina 27518
Dermavant Investigative Site High Point North Carolina 27262
Dermavant Investigative Site Wilmington North Carolina 28405
Dermavant Investigative Site Winston-Salem North Carolina 27157
Dermavant Investigative Site Beachwood Ohio 44122
Dermavant Investigative Site Bexley Ohio 43209
Dermavant Investigative Site Norman Oklahoma 73071
Dermavant Investigate Site Norman Oklahoma 73072
Dermavant Investigative Site Norman Oklahoma 73072
Dermavant Clinical Site Gresham Oregon 97030
Dermavant Investigative Site Portland Oregon 97210
Dermavant Investigative Site Portland Oregon 97223
Dermavant Investigative Site Pittsburgh Pennsylvania 15213
Dermavant Investigative Site Johnston Rhode Island 02919
Dermavant Investigative Site Charleston South Carolina 29407
Dermavant Investigative Site Nashville Tennessee 37215
Dermavant Investigative Site Arlington Texas 76011
Dermavant Clinical Site Bellaire Texas 77401
Dermavant Investigative Site College Station Texas 77845
Dermavant Investigative Site Dripping Springs Texas 78620
Dermavant Investigative Site Houston Texas 77004
Dermavant Clinical Site Houston Texas 77030
Dermavant Investigative Site Pflugerville Texas 78660
Dermavant Investigative Site Plano Texas 75024
Dermavant Investigative Site San Antonio Texas 78213
Dermavant Investigative Site San Antonio Texas 78229
Dermavant Investigative Site Webster Texas 77598
Dermavant Investigative Site West Jordan Utah 84088
Dermavant Investigative Site Norfolk Virginia 23502
Dermavant Investigative Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04053387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04053387 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →